Best Life Sciences Companies in Moscow, Russia
The 53 best Life Sciences companies in Moscow, Russia in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Incuron.
Our analysis of 576 Life Sciences companies
$91.7b in tracked funding; 70% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Moscow
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Incuron Specialty company developing drugs for treatment of cancer | $6M | 178 mo ago | Deadpooled | Andrei Leonov CEO | 2009 | — | 31 patents Patents concentrated in health & consumer products | — |
| 2 | TheraMAB Develop immunotherapeutic monoclonal antibodies (MAbs) for treating diseases in the field of autoimmunity and… | $5M | 173 mo ago | Deadpooled | — | 2009 | — | 32 patents Patents concentrated in chemistry & materials | — |
| 3 | Motorica Provider of 3D-printed prosthetics | $4M | 18 mo ago | Public | — | 2015 | TildaCarrot questYandex.Metrika+10 | 7 patents Modular hand prosthetic components with spiroid reducers, electromechanical control, and touchscreen interaction. | — |
| 4 | ARNA Genomics Provider of medical data analysis and management platform | $4M | 70 mo ago | Series A | Egor Melnikov Founder & CEO | 2013 | — | — | — |
| 5 | Genotek Direct-to-consumer genomic tests | $2M | 121 mo ago | Seed | Artem Elmuratov Co-Founder | 2010 | SentryTypeScriptNode.js+24 | — | — |
| 6 | OncoMax MAbs for range of cancer indications | $1M | 175 mo ago | Deadpooled | Anton Tikhonov ex-CEO | 2010 | — | 3 patents Patents concentrated in chemistry & materials | — |
| 7 | iBinom Medical interpretation of NGS data | $530K | 153 mo ago | Deadpooled | Andrey Afanasyev CEO | 2012 | — | — | — |
| 8 | Openface Developer of personalised products for skin health | $333K | 52 mo ago | Seed | Kris Farber Co-Founder & CEO | 2018 | TildaTikTok PixelYandex.Metrika+16 | — | — |
Top 12 Life Sciences companies in Moscow
#1
Public · Moscow, Moscow · founded 2015 · 117 employees$4.1Mraised▾
Provider of 3D-printed prosthetics. It has developed a myoelectric hand prosthesis. The company develops prosthetics upper limb and has created an active traction hand prosthesis that can restore the functionality of the grip in the case of complex partial injury.
- Dec 2024Conventional Debt$998.7K
- Jan 2021Series A$4.1M
#2
Series A · Moscow, Moscow · founded 2013 · 7 employees$3.5Mraised▾
ARNA Genomics is a medical data analysis and management platform that helps researchers gather, store, and analyze drug trial data, especially of those that are used to treat cancer. Uses blockchain technology to create a repository of cancer detection and treatment information. ARNA Panacea enables researchers to maintain their lab notes on the blockchain, complete with timestamp and ownership details etched into it. This allows for cross-country collaboration between researchers easier and cheaper.
- Sep 2020Series A$3.5M
#3
Deadpooled · Moscow, Moscow · founded 2009$5.7Mraised▾
Incuron is engaged in developing a pipeline of drugs to treat oncology. Two molecules currently undergoing clinical development are CBL0102 and CBL0137. CBL0102 is structurally identical to an old antimalarial drug, quinacrine, widely used for the treatment and prophylaxis of malaria. CBL0102 is a potent inducer of p53 and inhibitor of NF-kB via FACT-suppressing activity which gives its anti-cancer properties. This led to the finding that CBL0102 is toxic to multiple types of cancer cells in vitro and in some mouse models of cancer. However peculiar bio-distribution of CBL0102 in vivo with maximal accumulation in liver and skin suggested its clinical use against cancers located in liver and skin (primary and metastatic).
- Sep 2011Grant (prize money)$5M
- Nov 2010Grant (prize money)$244.5K
- Series A$5.7M
#4
Deadpooled · Moscow, Moscow · founded 2009 · 4 employees$5Mraised▾
TheraMAB develops immunotherapeutic monoclonal antibodies (MAbs). These MAbs modulate the activity of T-lymphocytes and may provide new treatment options for diseases in the field of autoimmunity and cancer. Its pipeline product TAB08 is a humanized IgG4 monoclonal antibody specific for the human T-lymphocyte co-stimulatory receptor CD28 which is described as agonistic T-cells stimulation. TheraMAB was founded by the investment fund Bioprocess Capital Ventures and was granted $5M from Skolkovos Innovation Center.
- Feb 2012Grant (prize money)$5M
#5
Seed · Moscow, Moscow · founded 2010 · 65 employees$2.4Mraised▾
Genotek provides direct-to-consumer genomic tests. Customers can order a kit online, mail in their cheek swab and receive results that have been signed off by doctors and genetic counselors. Genotek can test for over 5000 genes and screen for 4500 inherited conditions.
- 2016Angel$2M
- 2013Seed$400K
#6
Seed · Moscow, Moscow · founded 2018$332.8Kraised▾
Openface has developed personalized serum based on the skin health of the individuals. The company uses the genetics, lifestyle, eating habits and other health data through an online test to identify skin health conditions. The company analyses the answers to the questions provided in the test to develop personalized serum-based skin health products for treating skin problems such as acne, oily sheen, enlarged pores, age-related changes and others.
- Mar 2022Seed$332.8K
#7
Deadpooled · Moscow, Moscow · founded 2010 · 1 employees$1Mraised▾
OncoMax is focussed on developing drugs for range of cancers. It is developing its lead candidate OM-RCA-01, a monoclonal antibody (MAb) that binds to the extracellular domains of Fibroblast Growth Factor Receptor 1(FGFR1) and prevents receptor interaction with fibroblast growth factors thus inhibiting signal transduction. This inhibition claims to possess antitumor activity. The candidate is currently completing the preclinical research and is being developed for luminal B subtype of breast cancer, renal cell carcinoma, squamous cell carcinoma of the Lung and metastatic prostate cancer. It is currently conducting additional studies necessary to complete a registration dossier and access the first phase of clinical study.
- Dec 2011Seed—
- Dec 2011Grant (prize money)$1M
#8
Deadpooled · Moscow, Moscow · founded 2012 · 9 employees$530Kraised▾
Aiming for the clinical next-gen sequencing market iBinom launched a human genome interpretation service. iBinom Saas platform is an end-to-end genome interpretation solution for diagnostics of Mendelian and non-Mendelian diseases, tumor profiling, and drug response biomarker discovery studies. iBinom uses Amazon EC2, proprietary algorithms, machine learning technology and special design of medical report to make inherited disease diagnostics simpler and faster.
- Oct 2013Seed$100K
- May 2013Seed$130K
#9
Seed · Moscow, Moscow · founded 2017$72.1Kraised▾
Provider of a genetic test for detection of cancer. The tests analyze various specific genes that protect us from cancer, for the presence of mutations, and determine the risk of disease. The test also helps in personalized treatment.
- Jun 2018Seed$72.1K
#10
Seed · Moscow, Moscow · founded 2018—raised▾
AI-powered literature search platform for molecular datasets. It offers a platform access to relevant and reliable scientific information related to chemistry, structures, literature, patents, and experimental data.
- Apr 2024Seed—
#11
Seed · Moscow, Moscow · founded 2014—raised▾
Developer of therapeutics to treat multiple diseases. The company focuses on the development of therapeutics targeting Cytochromes P450 by using a proprietary technology platform known as CRYSTA. The lead candidate of the company inlcude an aldosterone synthase inhibitor for cardio-metabolic indications. Additionally, it develops drugs for Alzheimer's disease, NASH anti-inflammatory, chronic kidney disease, and fungal infection.
- Feb 2022Seed—
#12
Seed · Moscow, Moscow · founded 2017—raised▾
Cashee provides a face recognition system for pharmacies to manage customer engagement. The AI system consists of a video cam installed at the cashier desk to analyze the customer in person and their purchased prescriptions which are stored in the platform. It also offers communication tools with the customers for refilling and ordering of medicines for optimizing the marketing and revenue cycles for the pharmacies.
- Oct 2018Seed—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology in Moscow is moving
A read on the academic research around Biotechnology in Moscow — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 75 papers.
Lomonosov Moscow State University leads Moscow's biotechnology research (75 papers, stance +0.38).
- Lomonosov Moscow State University35
- Moscow State Academy of Veterinary Medicine and Biotechnology named after Skryabin15
- Moscow State University12
- Moscow State Agroengineering University named after V.P. Goryachkin7
- Moscow Institute of Physics and Technology7
- Recombinant DNA2
- Escherichia coli2
- Proteasome1
- Cell culture1
- Cancer cell lines1
- Gene5
- Cell culture4
- Production (economics)3
- Mutation3
- microRNA2
- Genetic diversity4
- Introgression3
- Domestication3
- Plant disease resistance3
- Genome3
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.